ANGPTL2 and histiocytic sarcoma: In this sense, we have found similar results in HS patients, although ANGPTL2 was related to the severity of HS independently of BMI, the presence of metabolic syndrome, and serum levels of hs-CRP, indicating that it could be a biomarker of the HS severity by itself.